Insider and congress filings
Tenet Healthcare Corporation (THC)
Free on iOS and Android.
About Tenet Healthcare Corporation
from the company's filings and listing, as of Oct 26, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Chief executive
- Saumya Sutaria
- Employees
- 88,500
- Listed since
- -
- Market value
- $21.6B
- Price to earnings (12 mo)
- 10.3
- Net income per share, as reported (12 mo)
- $26.83
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 23, 2026 | $6.12 | $4.26 | $5.6B | $5.4B | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $4.82 | $4.17 | $5.4B | $5.4B | EPS beatRevenue in line |
| Q4 FY2025reported Feb 11, 2026 | $4.70 | $4.07 | $5.5B | $5.5B | EPS beatRevenue in line |
| Q3 FY2025reported Oct 28, 2025 | $3.70 | $3.34 | $5.3B | $5.3B | EPS beatRevenue in line |
| Q2 FY2025reported Jul 22, 2025 | $4.02 | $2.87 | $5.3B | $5.2B | EPS beatRevenue beat |
| Q1 FY2025reported Apr 29, 2025 | $4.36 | $3.12 | $5.2B | $5.1B | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 16, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Saum SutariaChairman and Chief Executive Officer | $1.5M | $31.7M | $9.9M | $43.1M |
| Tom ArnstEVP, Chief Administrative Officer, General Counsel and Corporate Secretary | $650K | $3.7M | $5.7M | $10.0M |
| Lisa FooEVP and Chief Operating Officer | $650K | $3.4M | $5.5M | $9.5M |
| Sun ParkEVP and Chief Financial Officer | $700K | $2.7M | $4.0M | $7.4M |
| Paola ArbourEVP and Chief Information Officer | $550K | $1.4M | $2.2M | $4.1M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $1.6B | 8,743,005 | +0.4% | 10.47% |
| T. Rowe Price Associates, Inc. | $1.5B | 7,957,449 | +5.8% | 9.53% |
| Boston Partners | $829.1M | 4,433,360 | +15.6% | 5.31% |
| Vanguard Portfolio Management LLC | $792.9M | 4,238,108 | -1.8% | 5.07% |
| FMR LLC | $747.3M | 3,994,545 | -48.6% | 4.78% |
| Vanguard Capital Management LLC | $728.5M | 3,894,189 | -0.4% | 4.66% |
| State Street Corp | $514.7M | 2,751,290 | +1.3% | 3.29% |
| Glenview Capital Management, LLC | $418.2M | 2,235,666 | +46.6% | 2.68% |
| Geode Capital Management, LLC | $352.7M | 1,884,982 | -2.4% | 2.26% |
| Citadel Advisors LLCKen Griffin | $330.3M | 1,765,596 | +321.6% | 2.11% |
| Arrowstreet Capital, Limited Partnership | $319.6M | 1,708,453 | +154.3% | 2.05% |
| Ameriprise Financial Inc | $311.5M | 1,664,068 | +11.5% | 1.99% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
Tracked fund managers holding THC
2 managers| Manager | Value | Shares | Share of book |
|---|---|---|---|
| Glenview CapitalLarry Robbins | $418.2M | 2,235,666 | 7.6% |
| Pentwater Capital Management | $143.1M | 765,000 | 0.9% |
2 of the 97 fund managers we track list THC shares among the largest positions in their latest 13F, filed for Q2 2026. A manager can hold it further down the book too, so this is a floor, not a count. Share of book is the position against the manager's whole disclosed 13F value.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
20 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| J. Robert KerreyDirector | Sold · 3 lines | 12,010 | $263.72 | $3.2M | Sep 14, 2026filed Sep 16, 2026 | 2d |
| Richard J. MarkDirector | Sold | 10,000 | $263.42 | $2.6M | Sep 10, 2026filed Sep 14, 2026 | 2d |
| Nadja WestDirector | Sold | 1,152 | $258.80 | $298K | Sep 2, 2026filed Sep 3, 2026 | 1d |
| Lisa Y. FooEVP, Chief Operating Officer | Sold | 24,000 | $266.32 | $6.4M | Aug 31, 2026filed Sep 1, 2026 | 1d |
| Saumya SutariaCEO | Sold · 3 lines | 50,000 | $274.02 | $13.7M | Aug 25, 2026filed Aug 26, 2026 | 1d |
| Saumya SutariaCEO | Sold · 2 lines | 50,000 | $278.71 | $13.9M | Aug 24, 2026filed Aug 26, 2026 | 2d |
| Cecil D. HaneyDirector | Sold | 1,300 | $278.03 | $361K | Aug 24, 2026filed Aug 26, 2026 | 2d |
| Tammy RomoDirector | Sold | 2,500 | $260.83 | $652K | Aug 7, 2026filed Aug 10, 2026 | 1d |
| Tammy RomoDirector | Sold | 4,922 | $264.15 | $1.3M | Aug 6, 2026filed Aug 10, 2026 | 2d |
| Roy BluntDirector | Sold | 600 | $262.68 | $158K | Aug 5, 2026filed Aug 7, 2026 | 2d |
| Lisa Y. FooEVP, Chief Operating Officer | Sold | 10,000 | $258.03 | $2.6M | Jul 29, 2026filed Jul 31, 2026 | 2d |
| James L. BiermanDirector | Sold | 5,000 | $244.96 | $1.2M | Jul 27, 2026filed Jul 28, 2026 | 1d |
| Paola M. ArbourEVP, Chief Information Officer | Sold | 10,878 | $243.90 | $2.7M | Jul 27, 2026filed Jul 28, 2026 | 1d |
| Christopher S. LynchDirector | Sold | 3,837 | $243.44 | $934K | Jul 27, 2026filed Jul 28, 2026 | 1d |
| J. Robert KerreyDirector | Sold · 5 lines | 5,638 | $174.52 | $984K | May 28, 2026filed May 29, 2026 | 1d |
| Nadja WestDirector | Sold | 3,000 | $177.35 | $532K | May 27, 2026filed May 28, 2026 | 1d |
| Paola M. ArbourEVP, Chief Information Officer | Sold | 6,500 | $238.43 | $1.5M | Mar 11, 2026filed Mar 13, 2026 | 2d |
| Thomas W. ArnstEVP, Chief Admin. Officer & GC | Sold · 2 lines | 8,000 | $238.85 | $1.9M | Mar 9, 2026filed Mar 10, 2026 | 1d |
| Thomas W. ArnstEVP, Chief Admin. Officer & GC | Sold | 24,000 | $234.04 | $5.6M | Mar 2, 2026filed Mar 3, 2026 | 1d |
| R. Scott RamseyPrincipal Accounting Officer | Sold · 3 lines | 8,017 | $232.70 | $1.9M | Mar 2, 2026filed Mar 3, 2026 | 1d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Cecil D. HaneyDirector | Gift | 150 | Aug 28, 2026 |
| Meghan FitzgeraldDirector | Stock award | 1,188 | May 27, 2026 |
| J. Robert KerreyDirector | Stock award | 1,464 | May 27, 2026 |
| Christopher S. LynchDirector | Stock award | 1,188 | May 27, 2026 |
| Tammy RomoDirector | Stock award | 1,188 | May 27, 2026 |
| James L. BiermanDirector | Stock award | 1,188 | May 27, 2026 |
| Cecil D. HaneyDirector | Stock award | 1,188 | May 27, 2026 |
| Richard W. FisherDirector | Stock award | 1,188 | May 27, 2026 |
| Nadja WestDirector | Stock award | 1,188 | May 27, 2026 |
| Richard J. MarkDirector | Stock award | 1,188 | May 27, 2026 |
| Roy BluntDirector | Stock award | 1,188 | May 27, 2026 |
| Vineeta AgarwalaDirector | Stock award | 1,188 | May 27, 2026 |
| Roy BluntDirector | Disposed to issuer | 493 | May 22, 2026 |
| Roy BluntDirector | Option exercise | 1,333 | May 22, 2026 |
| J. Robert KerreyDirector | Disposed to issuer | 607 | May 22, 2026 |
| J. Robert KerreyDirector | Option exercise | 1,643 | May 22, 2026 |
| Richard J. MarkDirector | Disposed to issuer | 493 | May 22, 2026 |
| Richard J. MarkDirector | Option exercise | 1,333 | May 22, 2026 |
| Cecil D. HaneyDirector | Disposed to issuer | 493 | May 22, 2026 |
| Cecil D. HaneyDirector | Option exercise | 1,333 | May 22, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Congress trades in THC
9 disclosures of 9 on record · median 39d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Jonathan L. JacksonSpouse | Stock | Sale | $1,001 - $15,000 | +38.7%After the saleS&P 500 +8.6% · +30.1 pts vs S&P 500 | Apr 15, 2026 | May 27, 2026 | 42d |
| Jonathan L. JacksonJoint | Stock | Sale | $15,001 - $50,000 | +40.4%After the saleS&P 500 +7.2% · +33.1 pts vs S&P 500 | Apr 20, 2026 | May 27, 2026 | 37d |
| Jonathan L. JacksonSpouse | Stock | Sale | $1,001 - $15,000 | +18.6%After the saleS&P 500 +9.8% · +8.8 pts vs S&P 500 | Feb 11, 2026 | Mar 12, 2026 | 29d |
| Jonathan L. JacksonJoint | Stock | Purchase | $15,001 - $50,000 | +35.9%S&P 500 +10.5% · +25.4 pts vs S&P 500 | Dec 10, 2025 | Jan 8, 2026 | 29d |
| Jonathan L. JacksonSpouse | Stock | Purchase | $1,001 - $15,000 | +43.6%S&P 500 +18.1% · +25.6 pts vs S&P 500 | Sep 3, 2025 | Oct 15, 2025 | 42d |
| Lisa C. McClainSpouse | Stock | Sale | $1,001 - $15,000 | +66.7%After the saleS&P 500 +20.4% · +46.3 pts vs S&P 500 | Aug 4, 2025 | Sep 12, 2025 | 39d |
| Lisa C. McClainSpouse | Stock | Purchase | $1,001 - $15,000 | +66.3%S&P 500 +26.4% · +40.0 pts vs S&P 500 | Jun 11, 2025 | Aug 13, 2025 | 63d |
| John James | Stock | Sale | $1,001 - $15,000 | +65.6%After the saleS&P 500 +38.0% · +27.6 pts vs S&P 500 | Sep 4, 2024 | Sep 6, 2024 | 2d |
| John James | Stock | Purchase | $1,001 - $15,000 | +399.1%S&P 500 +72.6% · +326.5 pts vs S&P 500 | Nov 10, 2023 | Sep 2, 2024 | 297d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in THC, filterable by party, chamber, type and account.
Questions
Are insiders buying or selling THC?
Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales.
Which members of Congress have traded THC?
Jonathan L. Jackson, Lisa C. McClain and John James disclosed THC transactions in the filings shown here.
How quickly are THC trades disclosed?
Insider filings on this page reached the public a median of 1 business day after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 39 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.